Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Dec 9;311(7019):1549–1552. doi: 10.1136/bmj.311.7019.1549

Parvovirus B19: an expanding spectrum of disease.

B Cohen 1
PMCID: PMC2548210  PMID: 8520401

Full text

PDF
1549

Images in this article

1549Fig 1
on p.1549
1550Fig 2
on p.1550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L., Cohen B. J., Mortimer P. P., Pereira M. S. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983 Jun 18;1(8338):1378–1378. doi: 10.1016/s0140-6736(83)92152-9. [DOI] [PubMed] [Google Scholar]
  2. Bansal G. P., Hatfield J. A., Dunn F. E., Kramer A. A., Brady F., Riggin C. H., Collett M. S., Yoshimoto K., Kajigaya S., Young N. S. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis. 1993 May;167(5):1034–1044. doi: 10.1093/infdis/167.5.1034. [DOI] [PubMed] [Google Scholar]
  3. Brown K. E., Hibbs J. R., Gallinella G., Anderson S. M., Lehman E. D., McCarthy P., Young N. S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994 Apr 28;330(17):1192–1196. doi: 10.1056/NEJM199404283301704. [DOI] [PubMed] [Google Scholar]
  4. Cohen B. J., Buckley M. M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988 Feb;25(2):151–153. doi: 10.1099/00222615-25-2-151. [DOI] [PubMed] [Google Scholar]
  5. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  6. Courouce A. M., Ferchal F., Morinet F., Muller A., Drouet J., Soulier J. P., Perol Y. Human parvovirus infections in France. Lancet. 1984 Jan 21;1(8369):160–160. doi: 10.1016/s0140-6736(84)90086-2. [DOI] [PubMed] [Google Scholar]
  7. Denning D. W., Amos A., Rudge P., Cohen B. J. Neuralgic amyotrophy due to parvovirus infection. J Neurol Neurosurg Psychiatry. 1987 May;50(5):641–642. doi: 10.1136/jnnp.50.5.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Faden H., Gary G. W., Jr, Korman M. Numbness and tingling of fingers associated with parvovirus B19 infection. J Infect Dis. 1990 Feb;161(2):354–355. doi: 10.1093/infdis/161.2.354. [DOI] [PubMed] [Google Scholar]
  9. Fairley C. K., Smoleniec J. S., Caul O. E., Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet. 1995 Nov 18;346(8986):1335–1337. doi: 10.1016/s0140-6736(95)92346-2. [DOI] [PubMed] [Google Scholar]
  10. Frickhofen N., Abkowitz J. L., Safford M., Berry J. M., Antunez-de-Mayolo J., Astrow A., Cohen R., Halperin I., King L., Mintzer D. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med. 1990 Dec 15;113(12):926–933. doi: 10.7326/0003-4819-113-12-926. [DOI] [PubMed] [Google Scholar]
  11. Gregg I. A new treatment for asthma: promotional expediency versus pharmaceutical responsibility. Br Med J (Clin Res Ed) 1984 Jan 7;288(6410):68–69. doi: 10.1136/bmj.288.6410.68-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jobanputra P., Davidson F., Graham S., O'Neill H., Simmonds P., Yap P. L. High frequency of parvovirus B19 in patients tested for rheumatoid factor. BMJ. 1995 Dec 9;311(7019):1542–1542. doi: 10.1136/bmj.311.7019.1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kelleher J. F., Luban N. L., Mortimer P. P., Kamimura T. Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr. 1983 May;102(5):720–722. doi: 10.1016/s0022-3476(83)80243-1. [DOI] [PubMed] [Google Scholar]
  14. Kurtzman G. J., Cohen B., Meyers P., Amunullah A., Young N. S. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988 Nov 19;2(8621):1159–1162. doi: 10.1016/s0140-6736(88)90233-4. [DOI] [PubMed] [Google Scholar]
  15. Kurtzman G. J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N. S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987 Jul 30;317(5):287–294. doi: 10.1056/NEJM198707303170506. [DOI] [PubMed] [Google Scholar]
  16. Lefrere J. J., Bourgeois H. Human parvovirus associated with erythroblastopenia in iron deficiency anaemia. J Clin Pathol. 1986 Nov;39(11):1277–1278. doi: 10.1136/jcp.39.11.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Li Loong T. C., Coyle P. V., Anderson M. J., Allen G. E., Connolly J. H. Human serum parvovirus associated vasculitis. Postgrad Med J. 1986 Jun;62(728):493–494. doi: 10.1136/pgmj.62.728.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lyon D. J., Chapman C. S., Martin C., Brown K. E., Clewley J. P., Flower A. J., Mitchell V. E. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet. 1989 May 13;1(8646):1085–1085. doi: 10.1016/s0140-6736(89)92488-4. [DOI] [PubMed] [Google Scholar]
  19. Malm C., Fridell E., Jansson K. Heart failure after parvovirus B19 infection. Lancet. 1993 May 29;341(8857):1408–1409. doi: 10.1016/0140-6736(93)90973-k. [DOI] [PubMed] [Google Scholar]
  20. McOmish F., Yap P. L., Jordan A., Hart H., Cohen B. J., Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol. 1993 Feb;31(2):323–328. doi: 10.1128/jcm.31.2.323-328.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morfini M., Longo G., Rossi Ferrini P., Azzi A., Zakrewska C., Ciappi S., Kolumban P. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus. Am J Hematol. 1992 Feb;39(2):149–150. doi: 10.1002/ajh.2830390217. [DOI] [PubMed] [Google Scholar]
  22. Mortimer P. P., Luban N. L., Kelleher J. F., Cohen B. J. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983 Aug 27;2(8348):482–484. doi: 10.1016/s0140-6736(83)90512-3. [DOI] [PubMed] [Google Scholar]
  23. Nigro G., Zerbini M., Krzysztofiak A., Gentilomi G., Porcaro M. A., Mango T., Musiani M. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet. 1994 May 21;343(8908):1260–1261. doi: 10.1016/s0140-6736(94)92154-7. [DOI] [PubMed] [Google Scholar]
  24. Nikkari S., Roivainen A., Hannonen P., Möttönen T., Luukkainen R., Yli-Jama T., Toivanen P. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis. 1995 Jul;54(7):597–600. doi: 10.1136/ard.54.7.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Sullivan M. G., Anderson D. C., Fikes J. D., Bain F. T., Carlson C. S., Green S. W., Young N. S., Brown K. E. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest. 1994 Apr;93(4):1571–1576. doi: 10.1172/JCI117136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Okumura A., Ichikawa T. Aseptic meningitis caused by human parvovirus B19. Arch Dis Child. 1993 Jun;68(6):784–785. doi: 10.1136/adc.68.6.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981 Mar 21;1(8221):664–665. doi: 10.1016/s0140-6736(81)91579-8. [DOI] [PubMed] [Google Scholar]
  28. Paver W. K., Clarke S. K. Comparison of human fecal and serum parvo-like viruses. J Clin Microbiol. 1976 Jul;4(1):67–70. doi: 10.1128/jcm.4.1.67-70.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Porter H. J., Quantrill A. M., Fleming K. A. B19 parvovirus infection of myocardial cells. Lancet. 1988 Mar 5;1(8584):535–536. doi: 10.1016/s0140-6736(88)91332-3. [DOI] [PubMed] [Google Scholar]
  30. Ramage J. K., Hale A., Gane E., Cohen B., Boyle M., Mufti G., Williams R. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet. 1994 Mar 12;343(8898):667–668. doi: 10.1016/s0140-6736(94)92659-x. [DOI] [PubMed] [Google Scholar]
  31. Saal J. G., Steidle M., Einsele H., Müller C. A., Fritz P., Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12(4):147–151. doi: 10.1007/BF00274934. [DOI] [PubMed] [Google Scholar]
  32. Shneerson J. M., Mortimer P. P., Vandervelde E. M. Febrile illness due to a parvovirus. Br Med J. 1980 Jun 28;280(6231):1580–1580. doi: 10.1136/bmj.280.6231.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Watanabe T., Satoh M., Oda Y. Human parvovirus B19 encephalopathy. Arch Dis Child. 1994 Jan;70(1):71–71. doi: 10.1136/adc.70.1.71-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weiland H. T., Salimans M. M., Fibbe W. E., Kluin P. M., Cohen B. J. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol. 1989 Feb;71(2):300–300. doi: 10.1111/j.1365-2141.1989.tb04276.x. [DOI] [PubMed] [Google Scholar]
  35. White D. G., Woolf A. D., Mortimer P. P., Cohen B. J., Blake D. R., Bacon P. A. Human parvovirus arthropathy. Lancet. 1985 Feb 23;1(8426):419–421. doi: 10.1016/s0140-6736(85)91145-6. [DOI] [PubMed] [Google Scholar]
  36. Wierenga K. J., Pattison J. R., Brink N., Griffiths M., Miller M., Shah D. J., Williams W., Serjeant B. E., Serjeant G. R. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet. 1995 Aug 19;346(8973):475–476. doi: 10.1016/s0140-6736(95)91324-6. [DOI] [PubMed] [Google Scholar]
  37. Yee T. T., Lee C. A., Pasi K. J. Life-threatening human parvovirus B19 infection in immunocompetent haemophilia. Lancet. 1995 Mar 25;345(8952):794–795. doi: 10.1016/s0140-6736(95)90673-8. [DOI] [PubMed] [Google Scholar]
  38. Yoto Y., Kudoh T., Asanuma H., Numazaki K., Tsutsumi Y., Nakata S., Chiba S. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet. 1994 Aug 27;344(8922):624–625. [PubMed] [Google Scholar]
  39. Zanella A., Rossi F., Cesana C., Foresti A., Nador F., Binda A. S., Lunghi G., Cappellini M. D., Furione M., Sirchia G. Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion. 1995 Sep;35(9):769–772. doi: 10.1046/j.1537-2995.1995.35996029163.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES